Status:

COMPLETED

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

Lead Sponsor:

Technical University of Munich

Conditions:

Schizophrenia

Schizophrenia and Disorders With Psychotic Features

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

The main objective of the trial is to evaluate, how long an antipsychotic relapse-prevention should be continued and to which time a patient with schizophrenia is protected enough, so that a withdrawa...

Detailed Description

The main objective of the trial is to evaluate for the first time, how long an antipsychotic relapse-prevention should be continued and to which time a patient is protected enough, so that a guided wi...

Eligibility Criteria

Inclusion

  • Diagnosis of schizophrenia or schizoaffective disorder
  • The participants have to be in remission for at least 3 years (i.e. no psychiatric hospitalisation) under a stable antipsychotic medication. Remission will be measured using the remission criteria by Andreasen et al. (2005) Score ≤3 for the items concerning psychosis of the "Positive and Negative Syndrom Scale" (PANSS; Kay et al., 1987): "Delusions" (P1), "Conceptual disorganisation" (P2), "Halluzinations" (P3), "Mannerisms and posturing" (G5) and "Unusual thought content" (G9) and a score ≤3 on the "Clinical Global Impression Severity Scale" (CGI-S; Guy, 1976)
  • Able to give informed consent

Exclusion

  • Actively suicidal
  • Serious medical illnesses
  • Known non-complience concerning the medication
  • Medication with clozapin
  • Medication with antidepressants and mood stabilisors that were initiated during the last 6 weeks before study enrollment
  • Patients with substance dependence other than nicotine or caffeine within 6 months prior to baseline
  • Unability to give informed consent
  • Pregnancy

Key Trial Info

Start Date :

February 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 22 2016

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT02307396

Start Date

February 1 2015

End Date

June 22 2016

Last Update

October 11 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Psychiatrische Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen Universitaet Muenchen am Klinikum rechts der Isar

Munich, Bavaria, Germany, 81675